Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 16Genitourinary 15Thoracic 10Breast 10Lymphoid 9CNS 6Head & Neck 5Dermatologic 5Other hematologic neoplasm 4Gynecologic 4Plasma cell 3Endocrine 3Tumor-Agnostic 2Other solid neoplasm 2NET 2Myeloid 2Sarcoma 1

Conditions

Sarcoma 1Rhabdomyosarcoma 1

Interventions

Radiotherapy 216Cyclophosphamide 211Doxorubicin 207Temozolomide 181Ifosfamide 121Filgrastim 111Etoposide 101Imatinib Mesylate 99Vincristine 92Gemcitabine 89Bevacizumab 83Magnetic Resonance Spectroscopy 79Irinotecan 79pembrolizumab 75Radiation 67Carboplatin 65pazopanib 60Methotrexate 60Nivolumab 58Cisplatin 58fludarabine phosphate 56Peripheral Blood Stem Cell Transplantation 56Specimen Handling 53Docetaxel 50Busulfan 48Trabectedin 47Biopsy 47Melphalan 46Surgical Procedures, Operative 45Paclitaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Positron-Emission Tomography × Sarcoma × Clear all
NCT03054792 2026-04-29

Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas

The Hospital for Sick Children

Phase 1 Enrolling by invitation
18 enrolled
Sarcoma

Rhabdomyosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡